Gilles de la Tourette syndrome – A treatable condition?

A. Hartmann, D. Martino, T. Murphy

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


Introduction Gilles de la Tourette syndrome (GTS) is a neurodevelopmental disorder characterized by chronic motor and vocal tics. Psychiatric comorbidity is frequent but does not enter into the official classification of the syndrome. In the present article, we will focus on treatment options for tics. Methods We have reviewed the relevant literature on treatment of tics and GTS, especially in the period from 2011–2016 since the publication of the European Society for the Study of Tourette Syndrome (ESSTS) treatment guidelines in 2011. Results We present current and up-to-date approaches in psychotherapy, pharmacotherapy and neurosurgery for GTS with an outlook for the upcoming years. Conclusions Although many patients and health-care professionals seem to view tics and/or GTS as difficult to treat, or believe that treatment requires severe side effects with reduction in quality of life, we wish to convey that there is cause for optimism, both with regard to available treatment modalities and future therapeutic developments.
Original languageEnglish
JournalRevue Neurologique
Early online date28 Jul 2016
Publication statusE-pub ahead of print - 28 Jul 2016


  • Tics
  • Gilles de la Tourette syndrome
  • Psychotherapy
  • Pharmacotherapy
  • Deep brain stimulationés
  • Syndrome Gilles de la Tourette
  • Psychothérapie
  • Pharmacothérapie
  • Stimulation cérébrale profonde


Dive into the research topics of 'Gilles de la Tourette syndrome – A treatable condition?'. Together they form a unique fingerprint.

Cite this